Coloplast

The AI engine Fit Assessment

Beta

The company will be attending the 2024 Health Tech Forward Event

Blurb

Coloplast is a manufacturer of medical devices that offers ostomy, continence, and wound care products.

HQ Location

Humlebaek (Denmark)

Founded

1957

Employees

10000+

Total funding raised

$1.34B

Funding Status

Post-IPO Equity, $1.34B, August 29, 2023

Coloplast develops products and services to make life easier for people with deeply personal and private medical conditions. These conditions are often associated with trauma and taboo. The more intimate the condition, the greater the requirement to come closer to customers, understand their world and develop solutions that are sensitive to their special needs. We call this intimate healthcare.



Closeness to all customers makes this possible. We listen to better understand needs and respond by finding new ways to do things better together. We lead the way by bringing the best ideas first and fast to market in the form of medical devices and service solutions.



Deeply private and personal medical conditions are our focus. Our passion to make a real difference to people’s lives is what drives and unites us. Our culture supports high ambitions and releases the full potential of our own people to achieve them.



Our business includes Ostomy Care, Continence Care, Advanced Wound Care, Interventional Urology and Voice & Respiratory Care. We operate globally, employing more than 16,500 people.